IL6 and diabetes mellitus: showed that multiple inflammatory pathways are activated during the course of diabetes, leading to persistent low-grade, chronic inflammation and the release of pro-inflammatory cytokines including IL-1, IL-2, IL-6, and TNF-α [21].